OVERVIEW

The Cerebrospinal Fluid Management Market is expected to reach USD 1.75 billion by 2026, growing at a CAGR of 2.4% during the forecast period. Contributors to increase in the global demand of this market include development of techniques involved in the CSF management, further promoting the market demand, the growing global geriatric population which is providing growth opportunities for market growth. With the COVID-19 pandemic, the hospitals and many other healthcare organizations are dedicated to the treatment of patients suffering from these deadly diseases which has boosted the demand for the market.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Cerebrospinal Fluid Management Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Cerebrospinal Fluid Management Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Cerebrospinal Fluid Management Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Cerebrospinal Fluid Management Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Cerebrospinal Fluid Management Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Cerebrospinal Fluid Management Market ? By Type (Market Size ? & million/billion)
  • 8.1 Shunts
  • 8.2 External Drainage Systems

• 9 Global Cerebrospinal Fluid Management Market - By End-User
  • 9.1 Pediatric
  • 9.2 Adult
  • 9.3 Geriatric

• 10 Global Cerebrospinal Fluid Management Market ? By Geography (Market Size ? &

• • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 U.K
    • 10.3.2 Germany
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia-Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 South Korea
    • 10.4.5 Rest of APAC
  • 10.5 Rest of the World
    • 10.5.1 South America
    • 10.5.2 Middle East
    • 10.5.3 Africa

• 11 Global Cerebrospinal Fluid Management Market ? Entropy
  • 11.1 New product launches
  • 11.2 M&A's, collaborations, JVs and partnerships

• 12 Global Cerebrospinal Fluid Management Market Company Profile (Key Players)
  • 12.1 Market Share, Company Revenue, Products, M&A, Developments
  • 12.2 Medtronic
  • 12.3 Integra Lifesciences Holdings Corporation
  • 12.4 B. Braun Melsungen
  • 12.5 Spiegelberg GmbH & Co. Kg
  • 12.6 SOPHYSA (A Subsidiary of TKB Group)
  • 12.7 Natus Medical Incorporated
  • 12.8 Dispomedica GmbH
  • 12.9 Deltasurgical
  • 12.10 Argi Grup
  • 12.11 Moller Medical GmbH
  • 12.12 Company 11 & more

• 13 Global Cerebrospinal Fluid Management Market - Appendix
  • 13.1 Sources
  • 13.2 Abbreviations